Your browser doesn't support javascript.
loading
Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience.
Salvatori, Roberto; Maffei, Pietro; Webb, Susan M; Brue, Thierry; Loftus, Jane; Valluri, Srinivas Rao; Gomez, Roy; Wajnrajch, Michael P; Fleseriu, Maria.
Affiliation
  • Salvatori R; Division of Endocrinology and Metabolism and Pituitary Center, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. salvator@jhmi.edu.
  • Maffei P; Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Webb SM; Department of Endocrinology/Medicine, Centro de Investigación Biomédica en Red de Enfermedades Raras, Hospital Sant Pau, Universitat Autónoma de Barcelona, Carrer de Sant Quintí 89, 08041, Barcelona, Spain.
  • Brue T; Hopital de la Conception, and Aix-Marseille Université, Marseille Medical Genetics, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
  • Loftus J; Pfizer Ltd, Tadworth, UK.
  • Valluri SR; , Pfizer, New York, NY, USA.
  • Gomez R; Pfizer, Brussels, Belgium.
  • Wajnrajch MP; , Pfizer, New York, NY, USA.
  • Fleseriu M; Division of Pediatric Endocrinology, Grossman School of Medicine, New York University, New York, NY, USA.
Pituitary ; 25(3): 420-432, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35022929
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acromegaly / Human Growth Hormone Limits: Humans Language: En Journal: Pituitary Journal subject: ENDOCRINOLOGIA Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acromegaly / Human Growth Hormone Limits: Humans Language: En Journal: Pituitary Journal subject: ENDOCRINOLOGIA Year: 2022 Type: Article Affiliation country: United States